Sources
Our team is committed to scientific excellence
Liposome technology
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S.W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., Nejati-Koshki, K. (2013). Liposome: classification, preparation, and applications. Nanoscale Research Letters 8(1), 102. doi: 10.1186/1556-276X-8-102.
Briuglia, M.L., Rotella, C., McFarlane, A., Lamprou, D.A. (2015). Influence of cholesterol on liposome stability and on in vitro drug release. Drug Delivery and Translational Research 5(3), 231-42. doi: 10.1007/s13346-015-0220-8.
Chen, W., Zou, M., Ma, X., Lv, R., Ding, T., Liu, D. (2019). Co-Encapsulation of EGCG and Quercetin in Liposomes for Optimum Antioxidant Activity. Journal of Food Science 84(1), 111-120. doi: 10.1111/1750-3841.14405.
Kraft, J.C., Freeling, J.P., Wang, Z., & Ho R.J.Y. (2014). Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. Journal of Pharmaceutical Sciences 103(1), 29–52.
Bioavailability of active compounds
Martinez, M.N., Amidon, G.L. (2002). A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Journal of Clinical Pharmacology 42(6), 620-43.
Takahashi, M., Uechi, S., Takara, K., Asikin, Y., & Wada, K. (2009). Evaluation of an Oral Carrier System in Rats: Bioavailability and Antioxidant Properties of Liposome-Encapsulated Curcumin. Journal of Agricultural and Food Chemistry 57(19), 9141–9146.
Wajda, R., Zirkel, J., Schaffer, T. (2007). Increase of bioavailability of coenzyme Q(10) and vitamin E. Journal of Medicinal Food 10(4), 731-4.
DHA
Sun, G. Y., Simonyi, A., Fritsche, K. L., Chuang, D. Y., Hannink, M., Gu, Z., Greenlief, C. M., Yao, J. K., Lee, J. C., & Beversdorf, D. Q. (2018). Docosahexaenoic acid (DHA): An essential nutrient and a nutraceutical for brain health and diseases. Prostaglandins, leukotrienes, and essential fatty acids 136, 3–13. doi: 10.1016/j.plefa.2017.03.006.
Weiser, M. J., Butt, C. M., & Mohajeri, M. H. (2016). Docosahexaenoic Acid and Cognition throughout the Lifespan. Nutrients 8(2), 99. doi: 10.3390/nu8020099.
PEA
Davis, M. P., Behm, B., Mehta, Z., & Fernandez, C. (2019). The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review. The American journal of hospice & palliative care 36(12), 1134–1154. doi: 10.1177/1049909119850807.
Mattace Raso, G., Russo, R., Calignano, A., & Meli, R. (2014). Palmitoylethanolamide in CNS health and disease. Pharmacological research 86, 32–41. doi: 10.1016/j.phrs.2014.05.006.
Lutein
Mares J. (2016). Lutein and Zeaxanthin Isomers in Eye Health and Disease. Annual review of nutrition 36, 571–602. doi: 10.1146/annurev-nutr-071715-051110.
Ranard, K. M., Jeon, S., Mohn, E. S., Griffiths, J. C., Johnson, E. J., & Erdman, J. W., Jr (2017). Dietary guidance for lutein: consideration for intake recommendations is scientifically supported. European journal of nutrition, 56(Suppl 3), 37–42. doi: 10.1007/s00394-017-1580-2.
Melatonin
Andersen, L. P., Werner, M. U., Rosenkilde, M. M., Harpsøe, N. G., Fuglsang, H., Rosenberg, J., & Gögenur, I. (2016). Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC pharmacology & toxicology 17, 8. doi: 10.1186/s40360-016-0052-2.
Meng, X., Li, Y., Li, S., Zhou, Y., Gan, R. Y., Xu, D. P., & Li, H. B. (2017). Dietary Sources and Bioactivities of Melatonin. Nutrients 9(4), 367. doi: 10.3390/nu9040367
CBD
Fraguas-Sánchez, A. I., & Torres-Suárez, A. I. (2018). Medical Use of Cannabinoids. Drugs 78(16), 1665–1703. doi: 10.1007/s40265-018-0996-1.
Lucas, C. J., Galettis, P., & Schneider, J. (2018). The pharmacokinetics and the pharmacodynamics of cannabinoids. British journal of clinical pharmacology 84(11), 2477–2482. doi: 10.1111/bcp.13710.
Pisanti, S., Malfitano, A. M., Ciaglia, E., Lamberti, A., Ranieri, R., Cuomo, G., Abate, M., Faggiana, G., Proto, M. C., Fiore, D., Laezza, C., & Bifulco, M. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacology & therapeutics 175, 133–150. doi: 10.1016/j.pharmthera.2017.02.041.